Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe VIP152 trial record for relapsed/refractory chronic lymphocytic leukemia or Richter syndrome is displayed, with details on study design, participant criteria, locations, and measures. The record indicates the study was terminated due to slow enrollment and is no longer recruiting.SummaryDifference47%

- Check18 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedA notice appears above the ClinicalTrials.gov navigation announcing NIH website updates and a terminology transition. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the study page continues to show a 403 error.SummaryDifference0.2%

- Check60 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden error page. The error page blocks the display of the trial details and related content.SummaryDifference18%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.